What changed from existing technology?
This study shows that mesenchymal stromal cells stored for over 10 years under strict manufacturing conditions can still function properly after being thawed.
This is the first study to evaluate the long-term stability of GMP-cryopreserved MSCs over a 10-year period.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 3
inical applications. For therapeutic use, MSCs must be manufactured under Good Manufacturing Practice (GMP) conditions and cryopreserved to ensure product avail
Abstract ↗Long-term stability of GMP cryopreserved mesenchymal stromal cells after 10 years of storage. Mesenchymal stromal
Title ↗ducibility, yet evidence on their long-term stability remains limited. In this study, bone marrow-derived MSCs (BM-MSCs) expanded under GMP conditions an
Abstract ↗- 시제품·장치 구현 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
The results suggest that long-term cryopreservation of MSCs under GMP conditions may be a viable option for cell therapy manufacturing.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.